INDV
Indivior Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Christian Heidbreder sold $765K of Indivior Pharmaceuticals, Inc.
Sold$764,628
$41.14Price
18,586Shares
−8%Stake
What INDV did after the filing
- The stock from Tue, Jul 14 open, $40.51
- −11.6%
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the Aug 26 close.
Traded Fri, Jul 10. Filed Mon, Jul 13, 4:31 PM ET, after the close. Returns use the Jul 14 open and the Aug 26 close. Not investment advice.